Filana Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Filana Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- Filana Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was -450.42K shares, a 287.56% decline year-over-year.
- Filana Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 225.21K shares.
- Filana Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-06-30 was 225.21K shares.
- Filana Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 225.21K shares, a 6.22% decline from fiscal 2024.
- Filana Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 240.15K shares, a 60.14% decline from fiscal 2023.
- Filana Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 602.42K shares, a 195.83% increase from fiscal 2022.
- Filana Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 203.64K shares, a 15.73% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-07 | 0.00 shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | -450.42K shares derived: 10-K 12 month − 3 quarters · filed 2026-03-12 | 225.21K shares 10-K · filed 2026-03-12 |
| 2025-09-30 | 225.21K shares 10-Q · filed 2025-11-12 | 915.77K shares derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | 225.21K shares 10-Q · filed 2025-08-14 | 690.57K shares derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | 225.21K shares 10-Q · filed 2025-05-08 | 465.36K shares derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | 240.15K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 240.15K shares 10-K · filed 2025-03-03 |
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-07 | 107.12K shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-08-08 | 321.25K shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-10 | 583.40K shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-12-31 | 107.12K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 602.42K shares 10-K · filed 2024-02-28 |
| 2023-09-30 | 214.12K shares 10-Q · filed 2024-11-07 | |
| 2023-06-30 | 262.16K shares 10-Q · filed 2024-08-08 | |
| 2023-03-31 | 19.02K shares 10-Q · filed 2024-05-10 | |
| 2022-12-31 | 203.64K shares 10-K · filed 2023-02-28 | |
| 2021-12-31 | 98.48K shares derived: 10-K 12 month − 3 quarters · filed 2022-03-01 | 241.64K shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 4.90K shares 10-Q · filed 2021-11-15 | |
| 2021-06-30 | 3.24K shares 10-Q · filed 2021-11-15 | |
| 2021-03-31 | 135.01K shares 10-Q · filed 2021-11-15 | |
| 2020-12-31 | 71.11K shares 10-K · filed 2021-03-23 | |
| 2020-09-30 | 71.11K shares 10-Q · filed 2021-11-15 | |
| 2014-12-31 | 1.25M shares 10-K · filed 2015-02-18 | |
| 2013-12-31 | 287.45K shares 10-K · filed 2014-02-05 | |
| 2012-12-31 | 51.50K shares 10-K · filed 2013-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |